Artiva Biotherapeutics, Inc. ARTV Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Artiva Biotherapeutics, Inc. (ARTV) reported unrealized losses on investments (before tax) of $44K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax) decreased by 29.0% year-over-year, from $62K to $44K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s unrealized losses on investments (before tax) has grown at a -87.3% compound annual growth rate (CAGR), from $308K to $5K.